Clinical Trial Database Segmentation for Confidentiality

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current systems for managing clinical research trials are expensive and prone to errors due to insufficient documentation, recording, and communication, often compromising confidentiality and trial success.

Innovation Solution

A centralized secure database system with separate administrator and investigator databases, along with communication gateways and interfaces, facilitates secure and timely monitoring, recording, and communication of clinical research trial events, ensuring compliance with confidentiality laws while reducing costs and errors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current systems are used for managing clinical research trials, then confidentiality requirements are maintained, but the systems are expensive and prone to errors due to insufficient documentation and recording

Engineering Contradiction:
Improvedocumentation and recording accuracyVSAvoidsystem cost
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system divides the clinical trial management into separate databases for different user roles (administrators, investigators, participants) with specific access permissions. Each database contains only the information necessary for that role's functions, reducing complexity while improving documentation accuracy through role-based segmentation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a centralized secure database as an intermediary that facilitates communication and data sharing between administrators, investigators, and participants without requiring direct access to sensitive personal information. This mediator enables accurate documentation while maintaining confidentiality and reducing system complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If administrators access personal information of participants, then communication and coordination improve, but confidentiality requirements are compromised

Engineering Contradiction:
Improvecommunication efficiencyVSAvoidconfidentiality breach
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system implements local quality by providing different levels of information access to different user roles based on their specific needs. Administrators receive anonymized or aggregated data, investigators access participant information necessary for trial conduct, and participants control their own data sharing. This enables efficient communication while maintaining confidentiality through differentiated access rights.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The centralized secure database acts as an intermediary that enables communication between administrators and participants without requiring administrators to directly access personal information. The system mediates information flow by providing administrators with necessary trial management data while protecting participant privacy through controlled access mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Object-affected harmful factors

If separate databases are used for administrators and investigators, then confidentiality is maintained, but communication and coordination between roles become difficult

Engineering Contradiction:
Improveconfidentiality protectionVSAvoidinter-role communication
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The system implements universality by creating a centralized secure database that serves multiple functions: storing participant data, enabling researcher access, providing administrative oversight, and facilitating communication between all roles. This multi-functional database maintains confidentiality through access controls while enabling seamless inter-role communication and coordination.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent merges separate administrative and investigative databases into a unified centralized secure database that maintains distinct access pathways for different user roles. This combination enables efficient communication and coordination between administrators and investigators while preserving confidentiality through role-based access controls and secure data sharing mechanisms.

Inventive Principle:
Principle #5Merging (Combining)

4Device complexity

If manual tracking methods are used for participant events, then system cost is reduced, but errors in dispensing clinical trial protocol and insufficient monitoring occur

Engineering Contradiction:
Improvesystem costVSAvoidprotocol dispensing accuracy
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The system implements self-service by enabling participants to autonomously manage their own trial-related information, appointments, and communications through a user-friendly interface. Participants can view their schedules, update contact information, and access trial materials without requiring manual administrative intervention, reducing system costs while improving protocol accuracy through automated tracking and reminders.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The centralized secure database implements automated feedback mechanisms that monitor participant events, appointment adherence, and protocol compliance in real-time. The system automatically generates alerts and notifications to investigators and administrators when deviations occur, enabling timely corrective actions while reducing manual monitoring costs through automated surveillance and reporting.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS8688638B2System and method for management of research subject or patient events for clinical research trials
Publication Date: 2014.04.01 THE PATIENT RECRUITING AGENCY
  • US8688638B2 patent drawing
  • US8688638B2 patent drawing

AI summary

A system and method for managing clinical research trials is disclosed. The system and method may include a centralized secure database with information on clinical research trial participants, clinical research trial events, investigator and administrator inputs, and communication of participants, investigators and administrators. In one embodiment, the system and method allows investigators to contact participants without disclosing confidential contact information of the participants to the investigators by storing health information and contact information in separate databases. In one embodiment, administrators may access clinical research trial information through a secure web portal.